Los Angeles, Calif. and Hopkinton, Mass. — DxTerity Diagnostics, Inc. and Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that the companies have entered into a co-development and co-marketing strategic collaboration that will allow researchers to perform DxTerity’s NEATmultiplex diagnostic assays on Caliper’s LabChip Dx instrument platform minimizing sample processing time without compromising data quality. […]
Gaithersburg, Maryland and SEOUL, Korea – Seegene, the world’s leading developer of multiplex molecular diagnostics (M-MoDx), today announced the commercialization of its second real-time assay based upon its new TOCE™ technology. The Anyplex™ II RV16 Detection Assay will provide clinicians with a powerful new tool to help prevent the spread of respiratory infections. The Anyplex […]
SUNNYVALE, Calif. — Cepheid today reported revenues for the third quarter of 2011 of $70.2 million. Net income was $1.9 million, or $0.03 per share, which compares to revenues of $56.1 million and a net loss of $1.1 million, or $(0.02) per share, in the third quarter of 2010. Excluding amortization of purchased intangible assets […]
SAN DIEGO — Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Suber Huang, M.D., to its ophthalmology clinical advisory board. “As a firm supporter of the use of advanced genetic testing services, I look forward to advising Sequenom in delivering solutions that will help physicians advance patient […]
SAN DIEGO — Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced that its wholly-owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), launched its noninvasive proprietary MaterniT21 laboratory developed test (LDT). The MaterniT21 LDT detects a genetic chromosomal anomaly known as Trisomy 21, the most common cause of Down syndrome. […]
Shimadzu Corporation (President: Akira Nakamoto, situated in Nakagyo-ku, Kyoto, Japan) and Shimane University (President: Hiroki Yamamoto, situated in Matsue City, Shimane, Japan) have signed a joint research agreement for neonatal mass screening using tandem mass spectrometry. (Research period: October 15, 2011 to March 31, 2013.) In neonatal mass screening, blood sampled from newborn babies is […]
NEWCASTLE, England — QuantuMDx Group Limited, a handheld diagnostics and sequencing company, today announced that it has signed an exclusive license agreement with Nanosys Inc., an advanced materials architect, for several patents and patent applications related to the use of nanostructures for biosensors. The core intellectual property involves the use of nanowires and nanotubes in […]
Munich, Germany – Definiens®, the leading Health Image Intelligence™ company, today announced the release of its new Quantitative Digital Pathology portfolio, designed to advance translational research in pathology, specifically in biomarker development. The new portfolio will offer updated versions of Definiens Tissue Studio®, Definiens Developer XD™ as well as the introduction of a novel component, […]
TUCSON, Ariz.–HTG Molecular Diagnostics, has announced today it is entering the next phase of a multi-million, multi-institutional research project to develop technologies that would rapidly measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident. This $5M contract extension, $2.7M of which is HTG’s portion, is part of […]
THOROLD, ON – Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein preservation and purification from all type of specimens for research and molecular diagnostic applications, today announced successful accreditation to ISO 15189:2007 by the Standards Council of Canada (SCC). This ISO accreditation emphasizes our […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
